Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
LOC102723899 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
CLPX - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
ATRNL1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC101930026 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RIOK3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TOR1AIP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZNF626 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RAB33B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RNF13 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MTRR - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RNF6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CTBS - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TMEM30A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
BMPR1A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ATP4B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
APH1A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ANAPC13 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on